MARKET

NAMSW

NAMSW

NewAmsterdam Pha
NASDAQ
23.10
+0.10
+0.43%
Closed 12:27 01/02 EST
OPEN
23.50
PREV CLOSE
23.00
HIGH
23.50
LOW
23.10
VOLUME
220
TURNOVER
--
52 WEEK HIGH
29.99
52 WEEK LOW
5.45
MARKET CAP
--
P/E (TTM)
-11.4413
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NAMSW last week (1222-1226)?
Weekly Report · 12/29/2025 09:45
Weekly Report: what happened at NAMSW last week (1215-1219)?
Weekly Report · 12/22/2025 09:44
Weekly Report: what happened at NAMSW last week (1208-1212)?
Weekly Report · 12/15/2025 09:48
Weekly Report: what happened at NAMSW last week (1201-1205)?
Weekly Report · 12/08/2025 09:48
Weekly Report: what happened at NAMSW last week (1124-1128)?
Weekly Report · 12/01/2025 09:46
Weekly Report: what happened at NAMSW last week (1117-1121)?
Weekly Report · 11/24/2025 09:49
Weekly Report: what happened at NAMSW last week (1110-1114)?
Weekly Report · 11/17/2025 09:49
NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating
Seeking Alpha · 11/16/2025 15:30
More
About NAMSW
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMSW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMSW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMSW stock methods without spending real money on the virtual paper trading platform.